MA

Milind Arvind Killedar

Active Director Director DIN 00436156
DIN 00436156 First appointment Sep 1996 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Sep 1996
Shareholding value •••• Premium profile

About Milind Arvind Killedar

Data last updated:

Milind Arvind Killedar has 30 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Netraprabha Institute Of Refractive Surgery Private Limited and Anuradha Superspeciality Eye Hospital Llp. Formerly with 2 companies, such as Pragati Hospital Private Limited and Prathamesh Netra Seva Private Limited. Engaged in General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹1.28 Cr; the largest is Netraprabha Institute Of Refractive Surgery Private Limited at ₹1.16 Cr (FY 2025).

DIN 00436156
Primary Designation Director
First Appointment 26 Sep 1996
Oldest Company Age 24 yrs
Largest company Netraprabha Institute Of Refractive Surgery Private Limited · ₹1.16 Cr (FY 2025)
Combined revenue ₹1.28 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jun 20022002₹1.16 Cr (FY 2025)Active
Partner31 Aug 20222019₹11.8 Lakh (FY 2023)Active
Designated Partner10 Oct 20222022–Active
Designated Partner03 Apr 20182018–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pragati Hospital Private Limited U85193PN2012PTC141925
Director13 Jan 20122012₹1.45 Cr (FY 2025)Active
Director26 Sep 19961996₹8.5 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Netraprabha Institute Of Refractive Surgery Private Limited
Anuradha Superspeciality Eye Hospital Llp
Flynjoy Sports Llp
Abhinav Medicals Llp
Premium access

Shareholding and investment profile for Milind Arvind Killedar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Milind Arvind Killedar

Milind Arvind Killedar has 30 years in corporate governance. Holds Director and Designated Partner roles. Currently with 4 companies, including Netraprabha Institute Of Refractive Surgery Private Limited and Anuradha Superspeciality Eye Hospital Llp. Formerly with 2 companies, such as Pragati Hospital Private Limited and Prathamesh Netra Seva Private Limited. Engaged in General Business. The 2 current companies with reported revenue have a combined latest revenue of ₹1.28 Cr; the largest is Netraprabha Institute Of Refractive Surgery Private Limited at ₹1.16 Cr (FY 2025).

Milind Arvind Killedar is associated with 4 companies as Director and Designated Partner, including Netraprabha Institute Of Refractive Surgery Private Limited (₹1.16 Cr), Abhinav Medicals Llp (₹11.8 Lakh), Flynjoy Sports Llp.

Milind Arvind Killedar has expertise in General Business.

Milind Arvind Killedar has 30 years in corporate governance.

By reported revenue, the largest current company of Milind Arvind Killedar is Netraprabha Institute Of Refractive Surgery Private Limited, with revenue of ₹1.16 Cr (FY 2025).

The 2 current companies of Milind Arvind Killedar that report revenue have a combined latest revenue of ₹1.28 Cr.

Milind Arvind Killedar currently holds positions at 4 companies: Netraprabha Institute Of Refractive Surgery Private Limited (₹1.16 Cr), Abhinav Medicals Llp (₹11.8 Lakh), Flynjoy Sports Llp, Anuradha Superspeciality Eye Hospital Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available